CollPlant Biotechnologies Ltd.
CLGN
$2.29
-$0.1295-5.35%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | 689.00K | 10.62M | 10.96M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 689.00K | 10.62M | 10.96M | |
| Cost of Revenue | -- | 2.13M | 2.21M | 1.99M | |
| Gross Profit | -- | -1.44M | 8.41M | 8.97M | |
| SG&A Expenses | -- | 6.05M | 5.95M | 6.00M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | 19.09M | 18.95M | 18.47M | |
| Operating Income | -- | -18.41M | -8.32M | -7.51M | |
| Income Before Tax | -- | -17.47M | -7.50M | -7.02M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -17.47 | -7.50 | -7.02 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -17.47M | -7.50M | -7.02M | |
| EBIT | -- | -18.41M | -8.32M | -7.51M | |
| EBITDA | -- | -17.31M | -7.22M | -6.41M | |
| EPS Basic | -- | -1.53 | -0.65 | -0.61 | |
| Normalized Basic EPS | -- | -0.49 | 0.06 | 0.06 | |
| EPS Diluted | -- | -1.53 | -0.67 | -0.63 | |
| Normalized Diluted EPS | -- | -0.49 | 0.05 | 0.05 | |
| Average Basic Shares Outstanding | -- | 45.80M | 45.72M | 45.54M | |
| Average Diluted Shares Outstanding | -- | 45.80M | 46.13M | 45.94M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |